HIGHLIGHTS
- who: Xu Wang and collaborators from the Institute of Nervous System Diseases, Xuzhou Medical University, West Huaihai Road, Xuzhou, China have published the article: SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide, in the Journal: (JOURNAL) of 16/08/2022
- what: The authors report that inhibited glioma cell proliferation and down-regulated yes-associated protein (YAP) the key effector of the hippo pathway. The authors investigated the effect of SU4312 on glioma progression, both in_vitro and in_vivo.
- how: The results showed that SU4312 inhibited the viability . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.